Monoclonal
antibodies to squid neurofilament (aNFP) and intermediate filament (alFA) proteins were used as probes for the biochemical and immunocytochemical analyses of neurofilament structure and distribution in the squid giant axon and stellate ganglion.
On Western blots the aNFP antibody stained exclusively the 220 kDa and high-molecularweight (HMW) components of neurofilaments in the giant axon, whereas the alFA antibody primarily labeled the 60 kDa protein in the giant axon and the 60 and 65 kDa proteins in the stellate ganglion. Dephosphorylation of axoplasmic proteins by alkaline phosphatase resulted in a decrease in the molecular weights of both the 220 kDa and HMW neurofilament proteins and a concomitant loss of reactivity with the aNFP antibody on Western blots. This indicated that the aNFP antibody is specific for a phosphorylated epitope in the neurofilament.
Increased dephosphorylation of the 220 kDa protein led to an enhanced immunostaining of the resultant 190 kDa polypeptide by the alFA antibody, suggesting that the phosphorylated epitope may mask the conserved epitope recognized by alFA. Light and electron microscopic immunocytochemical studies show intense labeling by the aNFP antibody in the giant axon. In contrast, the alFA antibody labeled the glial cells around the giant axon intensely, while labeling of the giant axon itself was considerably less than that with the aNFP antibody. Since the 60 kDa protein in axoplasm is intensely stained by the alFA antibody on Western blots, the relatively low amounts of labeling seen on semithin and thin sections of the giant axon by this antibody may be due to the masking of the 60 kDa protein by in situ fixed axoplasmic proteins. However, the alFA antibody intensely labeled glial cells within the stellate ganglion and "islands" of filaments and nuclear membranes within ganglion cells. No reactivity for either antibody was seen in synapses.
The aNFP antibody specifically labeled "beadlike" portions and cross-bridges on the axonal neurofilaments, suggesting that these components consist of the 220 kDa and HMW proteins.
In contrast, the alFA antibody labeled relatively smooth filaments in ganglion and glial cells. These data suggest that the 65 kDa protein represents the squid glial filament protein and that the 60 kDa protein found in axoplasm represents the low-molecularweight subunit in the axonal neurofilament.
The latter appears to be formed and/or organized in "islands" of filaments within ganglion cells. These results support the view that the formation, maturation, and degradation of neurofilaments are regionally segregated within the neuron.
Neurofilaments are major components of the axonal cytoskeleton. Previous studies have indicated that neurofilament proteins isolated from the squid giant axon, as well as from other sources, appear to undergo posttranslational modifications by phosphorylation (Pant et al., 1978 (Pant et al., , 1979b Eagles, 198 1; Julien and Mushynski, 198 1, 1982; Sternberger and Sternberger, 1983) and limited proteolysis by a calcium-activated protease (Gilbert et al., 1975; Pant et al., 1979a; Pant and Gainer, 1980; Schlaepfer and Zimmerman, 1985) . In the squid axon, neurofilaments are composed of 2 major polypeptide subunits of 60 and 220 kDa, as well as a >400 kDa (HMW) protein (Pant et al., 1978; Lasek et al., 1979; Roslansky et al., 1980) . As is the case for mammalian systems (Leterrier et al., 198 1; Runge et al., 198 1; Julien and Mushynski, 1982; Pierre et al., 1985) phosphorylation of the higher-molecular-weight forms of squid neurofilament proteins (i.e., 220 and >400 kDa) occurs in axoplasm by the action of specific kinases (Pant et al., 1978 (Pant et al., , 1979b . In addition, a calcium-activated protease that selectively degrades neurofilament proteins has been demonstrated in squid axoplasm (Pant et al., 1979a (Pant et al., , 1982 Pant and Gainer, 1980; Gallant et al., 1986) . Extensive light and electron microscopic studies of the intact giant axon and isolated neurofilaments prepared under several different conditions have provided a view of the characteristic structure of squid neurofilaments. In the intact axon, there appear to be differences in the density of neurofilaments. The greatest concentration is at the periphery, where they are arranged in bundles; here they are more parallel than in central regions (Metuzals and Izzard, 1969; Hodge and Adelman, 1980) . A continuous 3-dimensional network in the giant axon, consisting of neurofilaments formed by intercoiled unit filaments with cross-bridge associations forming ladderlike patterns, has been described; squid neurofilaments also contain distinct "beadlike" portions along their length at regular intervals (Metuzals, 1969; Metuzals and Izzard, 1969; Adelman, 1980, 1983; Rice et al., 1980; Roslansky et al., 1980; Metuzals et al., 1981a Metuzals et al., , b, 1982 Metuzals et al., , 1983a Villegas and Villegas, 1984) .
In the present study, we make use of 2 monoclonal antibodies to determine the biochemical and morphological distribution of specific neurofilament proteins in the squid giant axon and stellate ganglion, and to correlate the state of phosphorylation of these polypeptides with their distribution and with specific neurofilament and neurofilament-associated structures. One of these antibodies (aNFP) specifically recognizes a phosphorylated epitope on the 220 kDa and HMW proteins, whereas the other (aIFA) strongly cross-reacts with the conserved rod region of all intermediate filament proteins (aIFA) (Pruss et al., 198 1; Cooper et al., 1984) , including the 60 kDa squid neurofilament protein. Recent advances in the use of colloidal gold-labeled secondary antibodies allow for the detailed localization of antibodies on resin-embedded tissue sections (Bendayan, 1983; Cohen et al., 1985) . Using these techniques, we have explored the general distribution of the 220 kDa subunit of neurofilament protein and 60 kDa subunit of intermediate filament protein within and around the giant axon and within the stellate ganglion of the squid by light and electron microscopic immunocytochemistry. We have also examined the locale of these subunits on neurofilaments and associated structures and on intermediate filaments. The morphological results are compared to biochemical data obtained on the distribution of these polypeptides using Western blots. In order to determine further whether the antibodies are specific for the phosphorylated epitopes on the polypeptides, dephosphorylation of neurofilaments with alkaline phosphatase was performed, and the resultant polypeptides were analyzed for immunoreactivity with the monoclonal antibodies on Western blots. In this way, we were able to correlate the phosphorylation states of the neurofilament subunits with their cellular distributions in the cell bodies and axons of the squid giant axon system.
Materials
and Methods
Biochemical studies
Isolation of axoplasm and stellate ganglion cell bodies. Axoplasm was isolated from squid giant axons of live squid (Loligo pealei) obtained at the Marine Biological Laboratory, Woods Hole, MA. The animals were maintained for a few hours in laboratory tanks containing running seawater before use. Dissection of the dorsal giant nerve fiber was performed under running seawater on a dissecting table illuminated from below through a glass window. These axons were about 60 mm in length and 400-600 pm in diameter. For convenience in subsequent manipulations, each end of the axon was ligated with thread prior to excision. Dark-field illumination and a dissecting microscope were used for extensive cleaning of the axon. The cleaned axons were rinsed in ice-cold isosmolar sucrose to remove the external seawater and blotted, and the axoplasm was extruded from the intact living axon in the conventional manner (Lasek, 1974 ) so as to avoid contamination of the axoplasm by seawater. Extruded axoplasm was quickly transferred into eppendorf tubes on ice containing-either a 5 &M EDTA, 40 mM Tris, 1 mg/ml leunentin. DH 7.0 solution or a 1 mM EGTA. 10 mM M&l,. 100 mM NaCl: 20'm~ HEPES, 50% glycerol, pH 7.O'solution, aid frozen for further use. The stellate ganglia were dissected in running seawater and rinsed briefly in ice-cold isosmolar sucrose; the cell body-containing region of the ganglion was excised, immediately homogenized in SDSgel homogenizing buffer (2% SDS, 5% 2-fl-mercaptoethanol), and stored frozen at -20°C. SDS-PAGE and Western blots. SDS-PAGE of squid tissue proteins was performed according to the methods of Nevelle (197 1) . Stacking gels were 4% acrylamide, and running gels were 7.5% acrylamide. The molecular weight standards used were: rabbit skeletal muscle myosin (2 12 kDa), Escherichia coli B-galactosidase (135 kDa), phosphorylase (90 kDa), BSA (68 kDa), pyruvate kinase (57 kDa), and ovalbumin (43 kDa). Gels were stained with 1 .O% Coomassie brilliant blue R (Bio Rad) in 7% acetic acid, 35% methanol for 12 hr, and destained in several changes of 7% acetic acid, 35% methanol. In cases where the tissue proteins were TCA precipitated (see below), all samples for SDS-PAGE were prepared as follows: SDS, 2%, was added to the TCA washed and acetone dried pellets, and the solution was heated at 100°C for 1 min. The sample was then reduced by adding 2% (by volume) 2+mercap-toethanol, in upper gel buffer (220 mM Tris-HCl and 0.1 N H,SO,, pH 6.1). Bromophenol blue (lo/o) was used as a tracking dye. Aliquots of 50-100 ~1(50-100 pg protein) samples were used for SDS-PAGE. Western blots were performed after electrophoretic transfer of proteins from the 7.5% acrylamide gel onto nitrocellulose paper. Transfer was carried out in a Hoefer Transphore unit for 15-l 8 hr at 15°C 60 V, 1000-2000 milliamps. The paper was then removed, blocked with 10% fetal calf serum in PBS for 18 hr, and then exposed overnight to 1:5 dilutions of culture supematants containing either aNFP or aIFA (see below) in 10% fetal calf serum, PBS. Following lo-12 washes in PBS, the second antibody, a 1:300 dilution of peroxidase labeled goat anti-mouse antibody (Boehrinaer Mannheim) in PBS. was atmlied for 2 hr. The uaper was then washed in Tris bukered saline (20-ma Tris, 0.9% NaCl, pH 7.2), 16 ml 4-chloro-1-napthol (3 mg/ml in methanol), and 32 ~1 of fresh 30% H,O,.
Deohosphorylation of squid axoplasm proteins. Extruded squid axoplasm (see above) waskxtensively-dialyzed at 4°C against dephosphorvlation buffer (50 mM Tris. 100 mM NaCl. 1 mM ZnSO,. DH 8.0) confaining 1 mM PMSF (Sigma) and 0.1 ms/ml each of leupeptin, pepstatin A, antipain, and bestatin (Peninsula Labs) to inhibit proteolysis. Various concentrations of E. coli alkaline phosphatase (type III R, Sigma) were added to 200 pg of axoplasm proteins in the above dephosphorylation buffer and incubated for 5 hr at 37°C. The reactions were terminated by precipitation in 10% TCA, and the TCA precipitates were prepared for SDS-PAGE and Western blots as described above.
Monoclonal antibodies to squid neurojilaments
Mouse monoclonal antibodies to squid axoplasm were prepared using conventional hybridoma procedures used in our laboratory (Ben-Barak et al., 1985) . The immunogen used to immunize BALB/c mice was glutaraldehyde-fixed extruded squid axoplasm, and the spleens of 3 mice showing high serum titers against axoplasm in enzyme-linked immunosorbent assay (ELISA) were used for fusion. Using ELISA and Western blot assays, we were able to obtain 5 distinct hybridoma clones that secreted antibodies that specifically reacted with the 220 kDa and HMW neurofilament proteins in squid axoplasm. One of these, clone 4D5C6(C8), which we designated aNFP, was exclusively used in this study (see Fig. 1 for Western blot stain using aNFP on axoplasm). Ouchterlony double-diffusion analysis showed that aNFP was an IgM. The anti-intermediate filament antibody (aIFA) was obtained from culture supematants of the aIFA hybridoma, ATCC T 1 B 13 1 (American Type Culture Collection, Rockville, MD). This antibody is an IgG, and cross-reacts with the conserved a-helical rod region in virtually all intermediate filaments (Pruss et al., 1981; Cooper et al., 1984) , including the 60 kDa neurofilament protein in axoplasm (Fig. 1 ).
Immunocytochemical studies
Fixation and embedding. Intact squid giant axons and stellate ganglia were dissected as described above and immediately immersed in 1% glutaraldehyde, 4% paraformaldehyde in calcium-free artificial seawater, pH 7.3-7.4. The giant axon was then cut into smaller pieces, and the stellate ganglion was subdivided further into areas containing predominantly ganglion cells or synapses. The pieces of tissue remained in the fixative overnight; the following day they were transferred to 0.1 M phosphate buffer, pH 7.4, and processed as follows.
The tissue was rinsed twice in 0.1 M phosphate buffer, pH 7.4, and then dehydrated and embedded in LR White (medium grade, Ernest F. Fullam, Inc., Latham, NY) according to previously published methods (Cohen et al., 1985) . Since LR White is sensitive to oxygen, gelatin capsules were used as embedding molds. In order to obtain longitudinal sections of the squid giant axon, the pieces were embedded according to the technique of Ridgway et al. (1984) . Disks made of hole punches of developed electron microscopy film were used as platforms for orienting the tissue. A tab for handling the disks with forceps was made by making 2 slits in the disk. The giant axon was then oriented horizontally in a drop of LR White placed on the disk. After a few drops aNFP alFA .* 60 Figure 1 . Western blots, using aNFP and aIFA, of squid axoplasm (A) and stellate ganglion cell body (SC) proteins. Note that the aNFP monoclonal antibody stained only the HMW and 220 kDa proteins in axoplasm (A) and showed virtually no staining in the stellate ganglion (G). The aIFA monoclonal antibody stained a number of proteins in axoplasm, the major band being the 60 kDa neurofilament protein (note the light band in SG corresponding to the 190 kDa protein in Fig. 3 ). In the SG sample, the aIFA intensely stained a 65 kDa band and exhibited a number of moderately stained bands, including a 60 kDa band.
of LR White were added to a predried gelatin capsule, the disk was gently placed in the capsule on top of the added resin. LR White was then added to the rest of the capsule, which was then covered with the top of the capsule to limit exposure to air. All capsules were polymerized overnight at 60°F.
Light microscopic immunocytochemistry
The immunocytochemical localization of the aNFP and aIFA monoclonal antibodies was performed on semithin (0.5-l .O pm) sections of LR White embedded giant axon and stellate ganglion. Colloidal gold (5 nm) was used as a probe, which was visualized by silver enhancement. In order to improve adhesion of the section onto the slide, the glass slides were individually wiped clean using ethanol-soaked optical lens tissue and placed in a slide staining rack. The rack was then dipped in a cooled 0.1% gelatin solution for -10 set and allowed to dry at either room temperature or in a mildly warm oven. Frosted slides were used to facilitate differentiating both sides ofthe slide. Semithin (OS-1 .O pm) sections were cut from each block and placed in drops of water on the slide. The slides were then permitted to dry on a hot plate. The use of separate slides for each antibody eliminated the possibility of crosscontamination.
Slides were placed on top of a grid box (or other platform) in a square Petri dish lined with a moist paper towel for all of the following immunocytochemical steps (except rinsing):
1. On a dry slide 200-300 pl of BSA (Grade V, Sigma Chemical Co., St. Louis, MO) were used to cover each group of sections, which were then incubated for 30 min at room temperature. The slides were then drained by permitting the drops of BSA to drip onto a paper towel. In order to prevent spreading in the next step, the areas around the sections were carefully wiped with a Kimwipe or filter paper. 2. The sections were then incubated with 50-100 ~1 of 5% normal goat serum (NGS) (Stemberger-Meyer Immunochemicals, Inc., Jarretsville, MD) in Tris-buffered saline (TBS) + 0.1% BSA (TBS-BSA) for 30 min at room temperature.
3. The sections were incubated with the aNFP (diluted 1:2) or aIFA (diluted 1:5) monoclonal antibodies or 1% NGS in TBS-BSA buffer as a control, overnight at 4°C.
4. The following day, the slides treated with the different antibodies were rinsed with TBS-BSA in separate Coplin jars placed on a shaker 3 times for 10 min each. After rinsing, the slides were wiped around the sections as described above and then returned to Petri dishes containing moist paper towels. 5. The sections were then incubated with 50-100 ~1 of secondary antibodies labeled with 5 nm colloidal gold (goat anti-mouse IgG; Janssen Pharmaceutics, Piscataway, NJ), diluted to -1:3, for 3 hr at room temperature. 6. The slides were then rinsed 3 times for 10 min each and drained as described above.
7. The slides were washed twice for 5 min each with PBS (pH 7.2). 8. The sections were then postfixed in 2% glutaraldehyde in PBS buffer for -5 min in order to prevent bleaching of the antibodies during subsequent harsh acid developing during the silver enhancement procedure. 9. The slides were then rinsed twice for 3 min each in PBS and then rinsed 3 times for 3 min in water or 6 min of continuous washing in distilled/deionized water. The silver enhancement procedure was performed according to the instructions in the Janssen Silver Enhancement Kit (Janssen Pharmaceutica, Piscataway, NJ) (De Mey, 1984) . Since the preparation of this manuscript, Janssen Pharmaceutics has issued a new kit, "IntenSE," that is light-insensitive. The following procedure, however, is based on instructions in the original kit. The procedure was carried out in the dark. The chemicals were weighed with the room lights out and placed in aluminum foil-covered glassware, as they are light-sensitive. All solutions were made fresh. The silver enhancement procedure is as follows.
1. Slides were placed in a prewash solution (20 ml citrate stock, made by dissolving 11.75 g trinatrium citrate 2H,O and 12.75 g citric acid H,O in 50 ml distilled/deionized water, and 180 ml distilled/deionized water) for 2 min.
-6% 60+ 2. While slides were in the prewash solution, the developer was made by pouring the hydroquinone solution (0.85 g hydroquinone in 15 ml distilled/deionized water) and the silver lactate solution (0.11 g silver lactate in 15 ml distilled/deionized water) into a second citrate solution (10 ml of citrate stock as described above in 60 ml distilled/deionized water). The resultant solution was shaken. It should be noted that the silver lactate and hydroquinone are not mixed together until moments before use, and this is done under a safelight.
3. The developer was poured into empty Coplin jars. The slides were placed in the Coplin jars containing the developer for 4-6 min at about 27°C.
4. The slides were transferred to a fixing solution (10 ml fixer in 90 ml distilled/deionized water) for no longer than 2 min. 5. The slides were transferred to distilled/deionized water and rinsed for 30 min in or out of the light. The control for the silver enhancement procedure involved incubating the silver enhancement chemicals on unlabeled tissue to see if there was any nonspecific development of the section.
Some sections were not processed for immunocytochemistry and, instead, were stained with 0.1% toluidine blue. After coverslips were placed on all slides, the sections were viewed with a bright-or darkfield condenser. The latter increases the contrast of the silver-enhanced colloidal gold particles. The sections were photographed with a Zeiss and Olympus BH2 photomicroscope.
Electron microscopic immunocytochemistry
The immunocytochemical localization of the, aNFP and aIFA monoclonal antibodies on thin sections of the squid giant axon and stellate ganglion using colloidal gold as a probe was performed according to previously published methods (Cohen et al., 1985) with minor modifications. These include the use of uncoated (i.e., no Formvar coat) nickel and/or gold grids. Since the antibody labels only those epitopes at the surface of the section, the use of uncoated grids doubles the number of sites available for labeling. The dilutions of the antibodies were the same as those described above for light microscopic immunocytochemistry.
The control involved incubating some sections with 1% NGS in TBS-BSA buffer. Both the aNFP and aIFA monoclonal antibodies also served as complementary controls for each other.
Technical considerations
The light microscopic immunocytochemical study presented here indicates that the silver enhancement of colloidal gold particles can be used on resin-embedded tissue labeled with primary antibodies and secondary antibodies labeled with colloidal gold. In the present study, the tissue was embedded in LR White, which has previously been shown to be useful for electron microscopic postembedding immunocytochemistrv usina biotin-streutavidin (Whitnall et al.. 1983 ) and colloidal gold (Craig and Miller, 1984; Cohen et al., 1985) as probes. The silveqenhancement technique can also be used with semithin Epon (Danscher and Norgard, 1983 ) and de-embedded (J. Wolosewick, personal communication) sections. Use of this technique on semithin resin embedded tissues is advantageous for the following reasons: (1) the improved resolution of the tissue over thicker vibratome or cryostat sections, (2) the improved resolution of the probe itself over fluorescent-or peroxidaselabeled secondary antibodies, (3) the ability to use the same block for light and electron microscopic immunocytochemistry when colloidal gold is used as a probe, (4) the quantitative view of the amount of immunoreactivity, (5) the stability of silver-enhanced gold particles over time, and (6) the possibility of counterstaining the sections (Danscher, 1981; Roth, 1982; Holgate et al., 1983; De Mey, 1984; Springall et al., 1984) . Also, the immunocytochemical results obtained with the silver enhancement technique can be viewed directly with bright-field microscopy, although a dark-field condenser was used to improve contrast in the present study.
Results

Western blot analysis and dephosphorylation studies
Analysis of the immunoreactivity of the aNFP and aIFA antibodies to proteins in the squid giant axon and stellate ganglion is illustrated in the Western blots in Figure 1 The overstaining in this series (e.g., at 0 pg AP) was due to use of a high concentration of antibody (i.e., undiluted culture supematant) in order to be certain that the loss of staining was not due to low antibody titer. A more typical staining of axoplasm using aNFP (at a 1:5 dilution of culture supematant) is shown in Figure 1 (first lane). In contrast to the above results, the efficacy of staining by aIFA was enhanced by increasing dephosphorylation (C). Note that upon presumed complete dephosphorylation (200 pg AP) the 190 kDa protein was as intensely stained, whereas the 60 kDa neurofilament proteins' intensity of staining was unaffected by AP treatment.
teins; no staining in the stellate ganglion was detected using this antibody. In contrast, the aIFA antibody intensely stained the 60 kDa protein in axoplasm, as well as a number of other proteins. In the stellate ganglion, however, the aIFA antibody intensely stained a 6.5 kDa protein and moderately stained some others, including one at 60 kDa.
Treatment of axoplasm by alkaline phosphatase had a marked effect on the mobilities of the 220 kDa and HMW proteins in the giant axon (Fig. 2) . Incubation of axoplasm (200 pg) with increasing concentrations (O-200 pg) of alkaline phosphatase resulted in an increased mobility on the SDS gel of the 220 kDa and HMW proteins. The 220 kDa band showed a gradual broadening with increasing alkaline phosphatase concentrations until a final sharp band at 190 kDa was visible with 200 Kg of alkaline phosphatase. The immunochemical analysis of squid axoplasm using the aNFP and aIFA monoclonal antibodies at various conditions of dephosphorylation is shown in Figure 3 . While the aNFP antibody intensely stains the 220 kDa and HMW proteins with no alkaline phosphatase treatment, there is a marked decrease in staining with incubation of 20 yg of alkaline phosphatase and a complete loss of staining at > 60 rg alkaline phosphatase (Fig. 3B) . In contrast, increasing concentrations of alkaline phosphatase resulted in an enhancement of staining of the dephosphorylated forms of the 220 kDa protein by the aIFA antibody (Fig. 3C ). When the 220 kDa protein was presumed to be completely dephosphorylated (200 Kg alkaline phosphatase) to yield the 190 kDa band (Fig. 3A) , the aIFA antibody stained the 190 kDa band as intcnscly as the 60 kDa protein, which was unaffected by alkaline phosphatase treatment (Fig.  3c ).
Light microscopic immunocytochemistry Giant axon. In order to assess the relative amounts of labeling of the aNFP and aIFA monoclonal antibodies in the squid giant axon and stellate ganglion, light microscopic immunocytochemistry was performed using silver-enhanced colloidal gold as a probe on semithin sections of LR White. Figure 4 shows the results of labeling of the giant axon with aNFP and aIFA antibodies using this technique. A toluidine blue-stained semithin section of a tangential view of the giant axon is seen in Figure   4a . The giant axon is surrounded by a thin glial cell, which is, in turn, surrounded by connective tissue containing fibrocytes and collagen bundles (Villegas and Villegas, 1984) . Figure 4b shows the labeling pattern of the giant axon with the aNFP antibody. The giant axon is intensely labeled, there is no labeling of the glial elements or connective tissue. While the aIFA antibody does label the giant axon, the degree of labeling is less than that with the aNFP antibody (Fig. 4~) . In contrast to the aNFP antibody, the aIFA antibody labeled the glial cell surrounding the giant axon intensely (Fig. 4~) . No labeling of the surrounding connective tissue was seen with the aIFA antibody.
Stellate ganglion. Figure 5 shows the results of 2 experiments (a-c, d-f) in which serial sections of the stellate ganglion were stained with aIFA and aNFP monoclonal antibodies. The stellate ganglion consists of neurons or ganglion cells (-50 pm in diameter) surrounded by glial cells. The ganglion cells are arranged in sets. In each set, the axons extending from the ganglion cells fuse to form a giant axon that innervates the mantle muscles; the hindmost and longest of these is known as the squid giant axon and forms the postsynaptic part of the giant synapse (Young, 1939; Villegas and Villegas, 1984) . These axons will synapse with the thinnest of the terminal branches of a secondorder axon from the palliovisceral ganglion behind the magnocellular lobe. Figure 5a is a toluidine blue-stained semithin section of a portion of the stellate ganglion where axons emerge. The neuropil of the ganglion consists of axons and synapses between the second-order fibers from the palliovisceral lobes and the third-order fibers, i.e., the giant axons of the stellate ganglion. Figure 5b shows labeling of these regions by the aIFA antibody. Labeling is associated with nuclear membranes of ganglion and glial (micrograph not shown) cells and glial cells themselves. The axons and general cytoplasm within the cell bodies are labeled to a small extent. Figure 5c shows the labeling pattern of a comparable area by the aNFP antibody; only the axons are intensely labeled. No label is detected in glial cells surrounding the axons and ganglion cells or within the ganglion cells themselves. Figure 5 (d-f) shows another region of stellate ganglion. A group of ganglion cells surrounding some axons are seen in the toluidine blue section in Figure 5d . A comparable section, labeled by the aIFA antibody, is shown in Figure 5e . Glial cells in between ganglion cells are labeled as are nuclear membranes of ganglion cells. Only a low degree of labeling is seen in axons and ganglion cells. A different pattern is obtained by labeling a similar area with the aNFP antibody; in this case, only axons are labeled (Fig. 5f) . A high-magnification view of ganglion cells stained with toluidine blue and a corresponding section labeled with the aIFA antibody are seen in Figure 6 , a and b, respectively. Glial cells surrounding ganglion cells are intensely labeled. Nuclear membranes of ganglion cells are also labeled. The general cytoplasm of ganglion cells is labeled to a small extent. Table 1 shows the relative amounts of immunoreactivity of aNFP and aIFA monoclonal antibodies in the giant axon and stellate ganglion as seen by light microscopic immunocytochemistry. No immunoreactivity was seen in control sections incubated with 1% NGS in TBS-BSA buffer or processed for silver enhancement without incubation with the primary antibody.
Electron microscopic immunocytochemistry Giant axon. In thin sections of squid giant axon embedded in LR White, neurofilaments are seen to consist of a straight portion, 10 nm wide, interrupted at regular intervals, -20-40 nm long, by "beadlike" portions, -30 nm wide (Fig. 7) . The micrograph seen in Figure 7a was taken from a region where the neurofilaments are not closely packed and organized in bundles. In this section of the giant axon, which was exposed to the aNFP monoclonal antibody, colloidal gold particles label the neurofilaments (Fig. 7a) . Specifically, the gold particles are associated with the beadlike portions located along the length of the neurofilament. In contrast to the extensive labeling of neurofilaments by the aNFP antibody, there was a markedly lower degree of labeling of neurofilaments by the aIFA antibody (Fig. 7b) . Because of the sparsity of the labeling, the exact location of the subunit along the length of the filament could not be discerned. Figure 7 , c and d, shows details of labeling of neurofilaments by the aNFP antibody. The micrographs were taken from a region of the axoplasm where the neurofilaments were more closely packed than these in the previous micrographs. Colloidal gold particles are seen to be specifically associated with the beadlike portions of the neurofilament. Fine filamentous material was often seen to project at right angles to the neurofilament, specifically from the beadlike portions. These thinner filaments, -5 nm in diameter, are comparable to the crossbridge associations previously described in the squid Adelman, 1980, 1983; Rice et al., 1980; Metuzals et al., 1982 Metuzals et al., , 1983a , as well as in other organisms (Ellisman and Porter, 1980; Ellisman, 198 between parallel neurofilaments. Apparent cross-bridges also show beadlike portions, although they are somewhat smaller (-8-16 nm) than those on the main portion of the neurofilament (Fig. 7, c and d) . Both the putative cross-bridge itself and its beadlike portions are labeled by the aNFP monoclonal antibody (Fig. 7, c and d) .
Differences in the labeling pattern between the aNFP and aIFA monoclonal antibodies were also seen in the glia surrounding the giant axon. Figure 8a shows filaments in a section of a glial cell surrounding the giant axon. In contrast to the neurofilaments located within the axon, the 10 nm glial filaments are relatively smooth (Fig. 8) . Figure 8a shows that sections incubated with the aIFA antibody contain colloidal gold particles that label the glial filaments. Another view of labeling of glial filaments by the aIFA antibody is shown in Figure 8b . In this figure, the relatively smooth surface of the glial filaments can be seen and compared to the nodose contours of the neurofilaments seen in the accompanying micrographs of Figure 7 . When Some labeling is also seen in the cytoplasm. x 5 14. similar glial sections were incubated with aNFP antibody, no colloidal gold labeling was observed (not illustrated).
Stellute ganglion. In the stellate ganglion, there was a small amount of labeling of the neurofilaments within axonal processes by the aIFA antibody (Fig. 9a) . As in the giant axon, the immunoreactivity within these smaller axons was markedly greater for the aNFP antibody (Fig. 9b) than for the aIFA antibody. Labeling by the aNFP antibody in the stellate ganglion was confined to neurofilaments within axonal processes. In contrast, the aIFA antibody labeled several areas within the stellate ganglion. In addition to axons, specific sites were labeled within ganglion and glial cells, although in varying degrees.
Ganglion cells usually possessed a varying number of "islands" of filaments within the cytoplasm (see Fig. 10 ). These islands were round, elongated, or irregularly shaped and were surrounded by rough endoplasmic reticulum. Moderate amounts of labeling of these filaments by the aIFA antibody are seen in (Fig. lob) . The filaments comprising these islands were relatively smooth compared to the neurofilaments, although occasionally fine strands of material could be seen to extend from them (Fig. lob) . A few round, dense structures, between -80 and 160 nm in diameter, were seen within the island and in close association with the network of filaments comprising the island (Fig. lob) . One ofthe most striking areas of labeling by the aIFA antibody was in filaments of glial cells (Fig. 11 ) in between the ganglion cells. Bundles of relatively smooth filaments (Fig. 11 a) showed strong reactivity to this antibody but no reactivity to the aNFP antibody (Fig. 1 lb) . Synapses in the neuropil of the stellate ganglion were examined for reactivity to both the aNFP and aIFA monoclonal antibodies. These antibodies did not label the presynaptic terminal, the synaptic vesicles, the postsynaptic process, or the cleft region (not illustrated). Table 1 summarizes the relative amounts of labeling by both monoclonal antibodies in the giant axon and stellate ganglion seen in the EM. No immunoreactivity was detected in control sections incubated with 1% NGS in TBS-BSA buffer.
Discussion
In this study we used 2 monoclonal antibodies to evaluate the phosphorylation state of the 220 kDa neurofilament protein in various topographical regions in squid neurons. The squid giant axon and the neuronal perikarya in the stellate ganglion are (arrow) interrupted at regular intervals by "beadlike" portions (double arrows). Extensive labeling of the neurofilaments by the aNFP antibody (a) is seen, whereas the labeling by aIFA (b) is markedly lower. Arrowheads indicate colloidal gold particles associated with the beadlike portions on the neurofilaments. x 75,000. Higher magnifications (x 120,000) of the aNFP-labeled neurofilaments are shown in c and d. Note that colloidal gold particles (largearrowheads) are associated with the small beadlike portions (smallarrowheads) and on putative cross-bridges between 2 neurofilaments (large arrows). The open arrow indicates colloidal gold labeling of the beadlike portion on an adjacent neurofilament. x 120,000.
excellent systems for such a study since both can be evaluated experimentally by biochemical as well as immunocytochemical procedures. Two posttranslational mechanisms are known to modify HMW neurofilaments: phosphorylation by specific protein kinases and proteolysis by calcium-activated neutral proteases (CANPs). The phosphorylation of neurofilaments is most extensive in the HMW neurofilament protein subunits, i.e., there are about 9-l 1 and 22 mol phosphate/m01 of 150 and 200 kDa mammalian neurofilament polypeptides, respectively (Julien and Mushynski, 1982; Georges et al., 1986) . Similarly, the 220 kDa neurofilament protein in the squid axon contains >20 mol phosphate/m01 polypeptide (P. A. M. Eagles, personal communication). These phosphates appear to be largely located in the carboxyl-terminal tail domains ofthe neurofilament proteins (Julien and Mushynski, 1983; Gallant et al., 1986; Pant et al., 1986) , and their functional significance is largely speculative at present. The neurofilament proteins are also acted upon by specific proteases (CANPs) present in axoplasm (Gilbert et al., 1975; Pant and Gainer, 1980; Pant et al., 1982) but normally do not become activated until the neurofilaments enter the nerve terminals (Lasek and Hoffman, 1976; Pant et al., 1982; Schlaepfer and Zimmerman, 1985) .
In this paper we have used the 2 monoclonal antibodies aIFA and aNFP to determine whether the phosphorylation of the 220 kDa squid neurofilament is similarly topographically regulated in the neuron. That such regulation occurs is suggested by im- The relative immunoreactivity of aNFP and aIFA monoclonal antibodies in squid giant axon and stellate ganglion was determined by Western blots and by light and electron microscopy. On Western blots, the aNFP antibodies labeled the 220 kDa and HMW proteins in axoplasm; no labeling by this antibody was seen in the stellate ganglion. In contrast, the aIFA antibody labeled the 60 kDa protein in axoplasm and the 60 kDa and 65 kDa proteins in the stellate ganglion. The aIFA antibody also labeled the dephosphorylated form of the 220 kDa protein, i.e., the 190 kDa protein. Immunocytochemical studies showed that labeling by the aNFP antibody was restricted to the giant axon and smaller axons within the stellate ganglion. Labeling by the aIFA antibody was seen in the giant axon to some extent but to a greater degree in the glial cells surrounding the giant axon. In addition, the aIFA antibody labeled several areas within stellate ganglion cells, including "islands" of filaments and nuclear membranes. Intense labeling by the aIFA antibody of glial cells surrounding axons and ganglion cells was seen. Symbols: + + + , intensely stained, + + , moderately stained; + , weakly stained; -, negative. munocytochemical analyses of phosphorylated neurofilament epitopes in mammalian systems (Sternberger and Sternberger, 1983) , and the observation of a putative neurofilament protein kinase inhibitor in squid neuronal perikarya preparations .
Specificities and properties of the aIFA and aNFP monoclonal antibodies The aIFA antibody reacts with all intermediate filaments, including neurofilaments (Pruss et al., 198 1; Pruss, 1985) . The epitope recognized by aIFA is located in the highly conserved rod domain of all intermediate filament proteins (Geisler et al., 1983; Phillips et al., 1983; Cooper et al., 1984) ; hence, reaction with this antibody can be used as an identification criterion for intermediate filament proteins in Western blot procedures. As can be seen in Figure 1 , aIFA staining of Western blots of squid axoplasm detect several positive bands, including the 60 and 190-220 kDa neurofilament proteins. These have previously been identified as neurofilament proteins by biochemical (Pant et al., 1978; Zackroff and Goldman, 1980; Tytell et al., 1985) and Bodian silver staining (Phillips et al., 1983) methods. The HMW neurofilament protein in squid axoplasm does not appear to react with aIFA ( Fig. 1 ) and reacts poorly with the Bodian silver stain (Phillips et al., 1983) . However, we identify the HMW protein in squid axoplasm as a neurofilament protein for several reasons: (1) It can react with aIFA under special conditions of staining (Pruss et al., 1981; Pruss, 1985) ; (2) it copurifies with 60 and 220 kDa proteins in neurofilament preparations from squid axoplasm (Pant et al., 1978 ; (3) it is phosphorylated by the squid neurofilament protein kinase and is degraded by the CANP in squid axoplasm ; and (4) the HMW protein reacts strongly with the aNFP antibody, which otherwise reacts only with the 220 kDa neurofilament protein (Fig. 1) . Given these data, we believe that the HMW protein (ca. 400 kDa) is a covalently linked dimer of the 220 kDa protein in squid axoplasm. The aIFA antibody reacts poorly with the phosphorylated form of the 200 kDa neurofilament protein. However, when this protein is extensively dephosphorylated by alkaline phosphatase, its reactivity is greatly increased (Fig. 30 . This suggests that the phosphates removed by this procedure were either sterically hindering access to or allosterically altering the state of the unphosphorylated epitope recognized by this antibody. This, in part, could account for the relatively weak labeling of axoplasm and neurofilaments by this antibody in immunocytochemical procedures (Figs. 4c, 7b) . Another reason for its weak labeling in immunocytochemical procedures is that the epitope of aIFA is located in the conserved rod domain of the molecule, which is involved in the coiled-coil structure of the neurofilaments. It is likely that after fixation of the tissue, these epitopes would be fixed in a location relatively inaccessible to the antibody. This is consistent with the general finding that antibodies to core domains (as opposed to end domains) of intermediate filaments perform relatively poorly in immunocytochemistry (Trojanowski et al., 1985) .
In contrast to the aIFA antibody, the aNFP antibody used here to identify the phosphorylated end domain of the 220 kDa neurofilament protein is very effective in both Western blot (Figs. 1, 3) and immunocytochemical (Figs. 4b; 5, c, A 7a) procedures. Hence, the lack of reactivity with Western blots of stellate ganglion cell body protein preparations (Fig. 1) and in immunocytochemistry of cell bodies (Fig. 5, b, c) , as opposed to its strong reactivity in immunocytochemistry of axons (Figs. 4b; 5, c, fl, argues strongly that the phosphorylated epitope in the 220 kDa protein recognized by aNFP is restricted to axonal regions in the neuron. It should be clarified here that these data do not directly address the issue whether all phosphorylation of the neurofilaments occurs solely intra-axonally. Since there are more than 20 phosphate groups in the end domain of the 220 kDa neurofilament protein, it is unlikely that aNFP (or any single antibody) could detect all of these. The data in Figure 3B show that aNFP detects a phosphorylated epitope and that this epitope can be removed by incubation with 60 rg alkaline phosphatase. However, the data in Figure 3 , A and C, also show that at this concentration (60 wg) of enzyme the 220 kDa protein has not yet reached its "fully dephosphorylated" state of 190 kDa. The latter form appeared to require 200 pg of enzyme. Presumably between 60 and 200 kg of enzyme incubation other phosphates not detected by aNFP were being removed from the 220 kDa neurofilament protein. Recently, Georges et al. (1986) have shown that exhaustive alkaline phosphatase treatment of the 200 kDa mammalian neurofilament protein, which lowered the apparent molecular weight of this protein on SDS gels, did not fully dephosphorylate the protein. After the phosphatase treatment the protein still contained 8 mol phosphate/m01 polypeptide, as compared to the original value of 22 mol phosphate/ mol polypeptide (Georges et al., 1986) . Hence, it is likely that the 190 kDa "dephosphorylated" neurofilament protein seen in Figures 2 and 3 also contains some residual phosphates. Therefore, by using aNFP as an immunological probe in these studies, Figure 9 . High-magnification electron micrograph of sections of small axons located within the stellate ganglion incubated with aIFA (a) and aNFP (e) monoclonal antibodies and secondary antibodies labeled with 10 nm colloidal gold. a, A moderate number of colloidal gold particles (arrowheads) are associated with filaments in small axons within a section of the stellate ganglion incubated with aIFA antibody. b, A large number of colloidal gold particles (arrowheads) are associated with filaments in small axons within the stellate ganglion incubated with aNPP antibody. x 60,000. Model for the topographical regulation of neurofilaments in squid stellate ganglion neurons. The 60 and 190 kDa neurofilament protein subunits-representing the putative core and unphosphorylated side-arm neurofilament components, respectively, in the squid-are synthesized and assembled for axonal transport in the cell body. This is consistent with the ability of the aIFA antibody to stain islands of smooth intermediate filaments in the cell body and the absence of aNFP (phosphorylated epitope) staining in the cell body. Since the appearance of aNFP staining is exclusively located in axonal structures both in the stellate ganglion and in the giant axon, we interpret this to mean that activation of the squid axon neurofilament protein kinase (SANFPK) is initiated somewhere in the region of the axonal initial segment (axon hillock), possibly regulated by an inhibitor of the SANFPK located in the cell body (see Pant et al., 1986) . In the giant axon, there is very little 190 kDa subunit, and virtually all of the HMW neurolilament protein subunits are either in the 220 or >400 kDa form (i.e., the HMW component), both of which stain intensely with aNFP ( Fig. 1 ) and are heavily phosphorylated by SANFPK. Both the 220 kDa and HMW proteins (we believe the HMW is a covalently linked 220 kDa dimer, unique to the giant axon) are greatly modified and rendered unreactive to aNFP by alkaline phosphatase treatment (Figs.  2 and 3) . The absence of detectable 60 kDa, 220 kDa, or HMW proteins in the nerve terminal by either immunocytochemical (not illustrated) or biochemical (Pant et al., 1982) methods is consistent with the proposal that the degradation of neurofilaments occurs in this site, in part, by the activation of calcium-activated neutral protease (CANP) and possibly a neurofilament protein (NFP)-specific phosphatase (see Lasek and Hoffman, 1976; Pant et al., 1982) .
we are evaluating the presence or absence of a particular phosphorylation epitope (or class of epitopes) in the HMW squid neurofilament protein. By using both of these characterized antibodies, we were able to correlate the staining patterns and intensities on Western blots with the immunocytochemical data so as to obtain a view of these specific epitopes in the context of neuronal morphology in the squid.
Immunocytochemical evidence for the topographic regulation of neurojlament protein phosphorylation Only small axons within the stellate ganglion show immunocytochemical labeling by the aNFP antibody (Figs. 5, c, i 9b) . In contrast, the aIFA antibody labels some of the stellate ganglion, particularly within the "islands" of filaments (Fig. 10a) . These islands are areas rich in filaments, most of which have smooth contours, although some have projections emanating from their surface. An interesting feature is the presence of dense bodies interspersed and in continuity with the filaments comprising the islands (Fig. lob) . Similar structures have been reported by Zackroff and Goldman (1980) cycles of assembly and disassembly and by Metuzals et al. (1983b) in fractions enriched with neurofilament protein complex. Zackroff and Goldman (1980) proposed that the dense bodies may function in neurofilament nucleation or organization. In this regard, we have also seen several dense bodies arranged in a compact group (not illustrated). Some filaments could be discerned emanating from the group and among the dense bodies within it. It may be that the disposition of these dense bodies in the present micrographs reflects their functional state. That is, when filament synthesis and/or assembly is in a quiescent state, the dense bodies show a compact disposition. On the other hand, during or after active filament synthesis, the dense bodies become separated by greater distances due to the appearance of increased amount of filaments. Within the islands, most of the filaments are relatively smooth compared to axonal neurofila-et al. * Distribution of Neurofilament i n Squid ments, although occasionally thin filamentous strands, reminiscent of the cross-bridges seen in the axonal neurofilaments, project from the surface. Similar results were obtained by other investigators, who showed that while neurofilaments of cell bodies and dendrites were cross-linked, the cross-bridges in the cell bodies were fewer and shorter than those in the axons; in other studies, no reaction was observed with antibodies against the HMW component of neurofilaments and the cross-bridges between neurofilaments in the cell bodies (Hirokawa et al., 1984) . Because the dominant low-molecular-weight form of the neurofilament protein stained by aIFA on Western blots in axoplasm is 60 kDa (Fig. l) , we presume that the aIFA-stained 60 kDa protein in the stellate ganglion blots in Figure 1 corresponds to the immunoreactive islands within the cell bodies (Fig. 10) . However, the most intense staining by aIFA on the Western blots of the stellate ganglion is at 65 kDa. Since both the light and electron microscopic immunocytochemistry of the stellate ganglion indicates that the most intense labeling by the aIFA antibody occurred in the glial cells surrounding ganglion cells and axons, we conclude that the 65 kDa protein very likely corresponds to glial intermediate filaments. Recent biosynthetic studies in which squid stellate ganglion cell bodies were incubated in vitro with "H-leucine have shown a de novo synthesis of the 60 kDa protein (Tytell et al., 1985) . In addition, recent 2-dimensional gel analysis of squid cell bodies from the stellate ganglion combined with Western blot staining with aIFA and aNFP have revealed 60 and 190 kDa aIFA immunoreactive proteins but no aNFP-immunoreactive 220 kDa proteins (M. Tytell, H. C. Pant, W. D. Hill, and H. Gainer, unpublished observations).
These differences in the morphology and biochemical composition of neurofilaments in the axon and stellate ganglion suggest that phosphorylation of neurofilaments does not occur in cell bodies but in the axon. In contrast to the relatively smooth contours of neurofilaments seen in the stellate ganglion, neurofilaments from the squid giant axon embedded in LR White consist of a straight portion interrupted by beadlike portions and cross-bridges. This view of the neurofilament is consistent with that obtained from studies of the configuration and organization of the neurofilamentous network in the intact giant axon and isolated neurofilaments prepared and/or treated in various ways (Metuzals, 1969; Metuzals and Izzard, 1969; Adelman, 1980, 1983; Rice et al., 1980; Metuzals et al., 198 1 b, 1982 Metuzals et al., 198 1 b, , 1983a Villegas and Villegas, 1984) . LR White is a useful embedding medium for the visualization of the cytoskeleton and its associated structures because its low electron opacity permits the visualization of the fine filaments that would ordinarily be obscured in epoxy resins (Cohen et al., 1985) . Using LR White, in the present case, various substructures comprising the neurofilament could be discerned. In addition, because the tissue was not exposed to osmium tetroxide before embedding in LR White, some structures appear negatively stained (Cohen et al., 1985) . This property may account for the appearance of the beadlike portions of neurofilaments in the present study. Such a configuration has been seen in negatively stained, antibody-decorated (i.e., with antibodies to the HMW component) mammalian neurofilaments (Willard and Simon, 1981) . We have observed filament morphologies and anti-IFA and anti-NFP labeling patterns in fixed neurofilamentenriched preparations prepared from axoplasm (not illustrated) that are very similar to those found in situ (Figs. 9, 10) .
Western blots revealed that the aNFP antibody stained only the HMW and 220 kDa proteins in the axoplasm. Parallel immunocytochemical studies demonstrated that the aNFP antibody labeled primarily the beadlike portions and the fine filamentous cross-bridges, which is consistent with the observations of mammalian neurofilaments (Willard and Simon, 1981) described above and with the suggestion by others that an -380 kDa protein (HMW in Fig. 1 ) in squid is attached to isolated 10 nm filaments and may be involved in cross-bridge structure Metuzals et al., 1982 Metuzals et al., , 1983b . Metuzals et al. (1982 Metuzals et al. ( , 1983a have tentatively assigned the 380 kDa (HMW) and 220 kDa polypeptides to the cross-linking, or radial, 5 nm filaments and the 60 kDa polypeptide to the axial, or 10 nm, filaments.
The aNFP antibody showed no immunoreactivity for the other major protein in axoplasm, i.e., the 60 kDa protein, on Western blots. Intense immunoreactivity for this protein in the axoplasm and on Western blots was observed with the aIFA antibody. The corresponding ultrastructural results show only a small amount of immunoreactivity for this antibody in the giant axon. Greater amounts of labeling were seen by this antibody on filaments within the stellate ganglion cell bodies and glial cells around the giant axon and ganglion cells. These results suggest that while the the 60 kDa protein is present in the neurofilaments of the axon, it is not readily accessible for immunocytochemical labeling under our fixation conditions. The filaments within the ganglion and glial cells show relatively smooth contours. The 60 kDa polypeptide may therefore correspond to the straight portion of the neurofilament seen in between the beadlike portions. Immunocytochemical studies on mammalian neurofilaments have shown that its HMW polypeptide is a component of the cross-bridge between neurofilaments, whereas its low-molecular-weight polypeptide is primarily a component of the central core of the filaments (Willard and Simon, 1981; Sharp et al., 1982; Hirokawa et al., 1984) . These studies are also in agreement with those on the in vitro assembly of neurofilaments from its high-, medium-, and low-molecular-weight components (Geisler and Weber, 198 1; Moon et al., 198 1; Liem and Hutchinson, 1982; Zackroff et al., 1982) . The low-molecularweight component is necessary and sufficient for the formation of intermediate-filament-like structures, indicating its importance in the formation of the central core. When the HMW polypeptide is included in the reaction mixture, it is incorporated into the filaments. The resultant filaments show projections (Geisler and Weber, 198 1; Moon et al., 198 1) on the surface, demonstrating that a portion of the HMW component extends peripherally from their central cores.
With regard to their functional properties, both the 220 kDa and HMW proteins are capable of being phosphorylated by endogenous kinases in whole axoplasm and neurofilament-enriched preparations as described above (Pant et al., 1978 (Pant et al., , 1979b . In the present study, dephosphorylation by alkaline phosphatase resulted in a decrease in molecular weights of the 220 kDa and HMW proteins, consistent with the removal of phosphorylated epitopes on both of these proteins. After dephosphorylation, immunochemical staining ofthe 220 kDa and HMW proteins by the aNFP antibody on Western blots was eliminated, demonstrating that this antibody recognizes the phosphorylated epitope on the neurofilament molecule. The generation of a 190 kDa polypeptide that is not labeled by the aNFP antibody after phosphatase treatment of the 220 kDa protein indicates that the latter consists of a phosphorylated epitope recognized by aNFP and a nonphosphorylated epitope recognized by aIFA. While dephosphorylation abolished immunochemical staining of the 220 kDa and HMW proteins by the aNFP antibody, increasing concentrations of alkaline phosphatase enhanced immunochemical staining by aIFA of the apparent dephosphorylated form of the 220 kDa protein, i.e., the 190 kDa protein. In fact, the 190 kDa protein became as intensely stained as the 60 kDa protein. That the 190 kDa polypeptide may be associated with the 60 kDa protein of the neurofilament or share similar epitopes with this protein is suggested by its light staining with high titers of the aIFA antibody on Western blots of stellate ganglion preparations . Similar results were obtained by Sternberger and Stemberger (1983) using tissue sections incubated with alkaline phosphatase. In these sections, they showed the appearance of reaction with antibodies staining only nonphosphorylated epitopes in structures that are usually stained only with antibodies to the phosphorylated epitopes, suggesting that dephosphorylation allows access to epitopes that were masked by phosphorylation (Stemberger and Stemberger, 1983) . These results are comparable to those in the present study, as their dephosphorylated epitope reacted with an anti-perikaryonal-neurofibrillar antibody and the phosphorylated epitope reacted with an anti-neurofibrillar antibody. Comparable results were also reported by Glicksman and Willard (1985) , who examined the dephosphorylation of the HMW component of mammalian neurofilaments and its subsequent loss of reactivity with antibodies to this polypeptide.
The final step in the regulation of neurofilament protein is its degradation by a Caz+-activated protease which selectively degrades neurofilament proteins and copurifies with them (Pant et al., 1979a (Pant et al., , 1982 Pant and Gainer, 1980; Gallant et al., 1986) . This degradation appears to occur in the axon terminal, where an increase in Ca2+ fluxes may contribute to the activation of the protease (Lasek and Hoffman, 1976; Pant et al., 1982) . Our present immunocytochemical study supports these findings, as no immunoreactivity for the aNFP or aIFA antibody was detected in presynaptic terminals (Table 1) .
Our results on the regional distribution of neurofilament proteins are in agreement with those from other laboratories using mammalian neurofilaments. Several investigators have shown that neurofilament proteins are not phosphorylated in nerve cell bodies, their dendrites, and proximal axons but are highly phosphorylated in the axons themselves (Stemberger and Stemberger, 1983) . Other studies have shown that the HMW protein is synthesized as a precursor which exhibits a change in isoelectric point and an increase in molecular weight with time (Oblinger and Schick, 1985) . It was suggested that the long time course of processing of neurofilaments seen may be due to posttranslational modifications that occur as neurofilaments enter the initial axon segments by axonal transport (Oblinger and Schick, 1985) . Furthermore, developmental studies indicate differences in the distribution of neurofilament components within the neuron (Willard and Simon, 1983) . It has been proposed that, in the adult, phosphorylation may play a role in stabilizing compacted forms of neurofilaments among themselves or other cytoskeletal elements. This idea is in agreement with that of Metuzals et al. (1983b) suggesting that neurofilaments serve as a scaffold for other axonal components and that the cross-bridges determine the order within the neurofilamentous network.
The biochemical and immunocytochemical data presented here show differences in the distribution of nonphosphorylated and phosphorylated epitopes of neurofilaments in the soma, axon, and nerve terminal regions of squid neurons. These data and other studies on the squid nervous system (Pant et al., 1982 Gallant et al., 1986) , as well as related work in the literature on mammalian neurofilaments (Lasek and Hoffman, 1976; Stemberger and Stemberger, 1983; Oblinger and Schick, 1985; Schlaepfer and Zimmerman, 1985) lend support to the hypothetical model illustrated in Figure 12 , which summarizes the view that the formation, phosphorylation, and degradation of squid neurofilaments are topographically segregated in the neuron, i.e., biosynthesis and assembly in the cell body, phosphorylation in the axon, and degradation in the nerve terminal.
